skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Nucleic acids encoding mosaic HIV-1 gag proteins

Patent ·
OSTI ID:1332283

The disclosure generally relates to an immunogenic composition (e.g., a vaccine) and, in particular, to a polyvalent immunogenic composition, such as a polyvalent HIV vaccine, and to methods of using same.

Research Organization:
Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
Sponsoring Organization:
USDOE
DOE Contract Number:
AC52-06NA25396
Assignee:
LOS ALAMOS NATIONAL SECURITY, LLC (Los Alamos, MX
Patent Number(s):
9,492,532
Application Number:
14/689,957
OSTI ID:
1332283
Resource Relation:
Patent File Date: 2015 Apr 17
Country of Publication:
United States
Language:
English

References (22)

Delivery of exogenous DNA sequences in a mammal patent December 1996
Induction of a protective immune response in a mammal by injecting a DNA sequence patent December 1996
Generation of antibodies through lipid mediated DNA delivery patent December 1997
Ancestral and COT viral sequences, proteins and immunogenic compositions patent February 2010
Mosaic clade M human immunodeficiency virus type 1 (HIV-1) envelope immunogens patent May 2011
Immunogenic compositions comprising human immunodeficiency virus (HIV) mosaic Nef proteins patent February 2012
Nucleic acids encoding mosaic clade M human immunodeficiency virus type 1 (HIV-1) envelope immunogens patent April 2015
Human immunodeficiency virus type 1 clade M mosaic gag polypeptides patent April 2015
Mosaic clade M human immunodeficiency virus type 1 (HIV-1) gag immunogens patent June 2015
Antigen Library Immunization patent-application December 2002
Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-Gag, Pol, Nef and modifications patent-application March 2003
Method for the development of an HIV vaccine patent-application June 2003
Polyvalent immunogen patent-application August 2003
Immunogenic, cross-clade, HIV peptides patent-application September 2003
Peptide compositions for the treatment and prevention of HIV infection patent-application October 2003
Polyvalent immunogen patent-application January 2004
Ancestral and COT viral sequences, proteins and immunogenic compositions patent-application June 2005
HIV vaccines based on Env of multiple clades of HIV patent-application December 2006
Consensus/ancestral immunogens patent-application August 2007
Polyvalent Vaccine patent-application December 2009
Polyvalent Vaccine patent-application June 2011
Polyvalent Vaccine patent-application May 2012